Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dehou Deng"'
Autor:
Chao Lu, Guangliang Li, Dehou Deng, Rongrong Li, Xiaoyu Li, Xukang Feng, Taoping Wu, Xiying Shao, Weiji Chen
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionUtidelone (UTD1) is a new chemotherapeutic drug for recurrent or metastatic breast cancer. However, it usually leads to severe peripheral neuropathy (PN) and causes numbness of the hands and feet and significant pain in patients' life. El
Externí odkaz:
https://doaj.org/article/02fefe9c6fe648f08fd40e07b77d7242
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a common complication in patients with cancer during chemotherapy. It mainly leads to severe numbness of the hands and feet and causes great pain in patients. Electroacupuncture (EA) is
Externí odkaz:
https://doaj.org/article/7d3d93b878fe435c983963f5a86a4e59
Publikováno v:
Oncology Letters
This study investigated the effect of single-nucleotide polymorphisms (SNPs) of low-density lipoprotein receptor-related protein 5 (LRP5) on the risk of developing non-small cell lung cancer (NSCLC). A total of 500 NSCLC patients and 500 healthy cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec60304a5396630a48a7297784f3b2b
https://doi.org/10.3892/ol.2016.4954
https://doi.org/10.3892/ol.2016.4954
Research progress on common adverse events caused by targeted therapy for colorectal cancer (Review)
Publikováno v:
Oncology Letters.
As targeted drug therapy is increasingly applied in the treatment of colon cancer, understanding and managing the adverse reactions of patients is becoming increasingly important. The present review examines the mechanisms of and adverse reactions to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0965c44fde7eca8dc4c9e5af3f9ae331
https://doi.org/10.3892/ol.2018.8651
https://doi.org/10.3892/ol.2018.8651
Autor:
Lei Luo, Jianguo Feng, Yuheng Ding, Lei Shi, Xiaohong Xu, Wei-Wu Ye, Hanzhou Mou, Yabing Zheng, Xiaojia Wang, Xiying Shao, Yong Guo, Zhanhong Chen, Ping Huang, Yuan Huang, Dehou Deng, Cai-Jin Lou
It has been hypothesized that single nucleotide polymorphisms in CYP19A1 gene may alter aromatase activity and circulating steroid hormone levels in females. Therefore, it is biologically reasonable that CYP19A1 rs1008805 (A/G) polymorphism may be as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02a9bc72e300e7e6def6c0e00e7aef4
https://europepmc.org/articles/PMC5661487/
https://europepmc.org/articles/PMC5661487/
Publikováno v:
International Journal of Medical Sciences
Objectives: Low-density lipoprotein receptor-related protein 6 (LRP6) modulates Wnt signaling transduction. Altered LRP6 expression leads to abnormal Wnt protein activation, cell proliferation and tumorigenesis. This study investigated the associatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f128bd7a4feb1fda2fc4fbc480f4057
https://doi.org/10.7150/ijms.8852
https://doi.org/10.7150/ijms.8852
Publikováno v:
Clinical Lung Cancer. 14:45-49
Background Recently, polymorphisms in COMT (catechol-O-methyltransferase), PLCH1 (phosphoinositide-specific phospholipase C eta 1), and CYP17A1 (cytochrome P450 17A1 ) were found to be associated with the development of lung cancer in a non-Chinese p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6282e9cd966961299b64932eea9d01b8
https://doi.org/10.1016/j.cllc.2012.04.004
https://doi.org/10.1016/j.cllc.2012.04.004
Publikováno v:
Acta biochimica Polonica. 61(4)
Aims. This study aimed to investigate CHRNA3 (rs8040868) and PHACTR2 (rs9390123) single-nucleotide polymorphisms (SNPs) for association with non-small-cell lung cancer (NSCLC) risk in a Chinese population, and whether the environment affects the gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80561c2467a46ad94ee3713faca87c73
https://pubmed.ncbi.nlm.nih.gov/25399010
https://pubmed.ncbi.nlm.nih.gov/25399010
Autor:
Meiyu Fang, Guan Liu, Yunli Zhang, Xiao Zheng, Wenlong Bao, Dehou Deng, Weiming Mao, Shengye Wang
Publikováno v:
Oncology Letters
Epidermal growth factor receptor (EGFR) is an important therapeutic target in lung cancer. Gefitinib and erlotinib, two reversible EGFR receptor tyrosine kinases inhibitors (TKIs), have been approved for the treatment of patients with metastatic non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7692a03abb3792bd1efd4a89edac4e0
https://pubmed.ncbi.nlm.nih.gov/25202368
https://pubmed.ncbi.nlm.nih.gov/25202368
Autor:
Xiangming Kong, Danlin Gu, Hua Shi, Cuiping Gu, Lili Ren, Yongjun Zhang, Dehou Deng, Wenlong Bao, Aiqin Zhang
Publikováno v:
Gene. 497(1)
Recently, two genome-wide association studies in Asia identified gene polymorphisms known as rs4488809, rs9816619 in TP63 and rs2131877, rs952481 in C3orf21. It has been proposed that these polymorphisms are susceptibility loci for non-small cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12433c2fb08c7cabf8ea1b12549f67d6
https://pubmed.ncbi.nlm.nih.gov/22310392
https://pubmed.ncbi.nlm.nih.gov/22310392